San Francisco, 27 March 2019: The Report Biopharmaceutical Excipients Market Size, Share & Trends Analysis Report By Product
(Solubilizers & Surfactants/Emulsifiers, Specialty Excipients, Polyols,
Carbohydrates), By Region, And Segment Forecasts, 2019 - 2025
The global biopharmaceutical excipients market size is expected to reach USD 2.7 billion by 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 6.08% over the forecast period. Rapid expansion of the biopharmaceutical industry due to increasing manufacturing capacities is one of the key driving force of this market. Rise in the number of protein therapeutics coupled with the presence of a substantial number of excipients to protect these proteins from degradation is also driving the market growth.
Investigational studies that are implemented for the
impact analysis of excipient variability on in vitro dissolution
testing are expected to reduce the attrition rate of final products and
increase the reproducibility. These studies help scientists in gaining insights
on the in
vivo functioning and pharmacodynamic analysis of large
molecules. The market exhibits continuous need of innovative excipient
technologies to prolong the in vivo effectiveness
of biologics and for improvement in the product delivery. Moreover, extensive
R&D for the development of raw materials that help improve yields in
mammalian cell-culture processes is expected to drive the market in future.
Access Research Report of Biopharmaceutical Excipients Market
@ https://www.grandviewresearch.com/industry-analysis/biopharmaceutical-excipients-market
Further key findings from the study suggest:
· Easy availability and wide usage of
dextrose, sucrose, and starch in biopharmaceutical formulations has resulted in
the largest revenue share of carbohydrates
· Polyols is expected to be the
fastest-growing product segment in the global biopharmaceutical excipients
market
· This can be attributed to increasing
concerns regarding protein degradation, which can be reduced by using polyols
· North America led the global market in 2017
accounting for the largest revenue share as a result of the presence of key
biopharmaceutical manufacturers in U.S.
· Emerging markets, such as India and China,
are projected to be driven by the contract manufacturers operating in these
regions
· Some major biopharmaceutical excipient
suppliers are Merck KGaA; Roquette; Clariant; DFE Pharma; SPI Pharma, Inc.; and
JRS Pharma LP
· Most of these companies are engaged in
establishing partnerships with biopharmaceutical manufacturers to understand
their needs and develop raw materials specific to the process and end-product
Browse more reports of this category by Grand View
Research at: https://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has
segmented the global biopharmaceutical excipients market on the basis of
product and region:
Biopharmaceutical Excipients Product
Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·
Solubilizers & Surfactants/Emulsifiers
·
Polyols
·
Carbohydrates
·
Specialty Biopharmaceutical
Excipients/Others
Biopharmaceutical Excipients Regional
Outlook (Volume, Tons; Revenue, USD Million, 2014 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
Latin America
·
Middle East & Africa
Access Press Release of
Biopharmaceutical Excipients Market@ https://www.grandviewresearch.com/press-release/global-biopharmaceutical-excipients-market
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides
syndicated research reports, customized research reports, and consulting
services. To help clients make informed business decisions, we offer market
intelligence studies ensuring relevant and fact-based research across a range of
industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
No comments:
Post a Comment